Patient Group Directive- Promethazine (MHS MRG 52)

Warning

Resources

Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 10/01/2025

Next review date: 01/12/2026

Author(s): Safer Use of Medicines- Mental Health.

Version: 3

Approved By: Mental Health Clinical Governance Group

Reviewer name(s): Lead clinical Pharmacist, Clinical Effectiveness Pharmacist.